JABTUS TF 5 TABLET
Tofacitinib Tablets
Composition (Each tablet contains):
Tofacitinib: 5 mg
Dosage Form: Oral Tablet
Therapeutic Class: Janus Kinase (JAK) Inhibitor
(For Autoimmune & Inflammatory Disorders
Tofacitinib Tablets 5mg is indicated for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Tofacitinib 5mg is indicated for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It acts by decreasing inflammation and dampening the overactive immune response. It relieves pain, swelling, and stiffness of the joints as well as increases mobility. In ulcerative colitis, it decreases symptoms of diarrhea and pain in the abdomen
Tofacitinib 5mg is indicated for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It acts by decreasing inflammation and dampening the overactive immune response. It relieves pain, swelling, and stiffness of the joints as well as increases mobility. In ulcerative colitis, it decreases symptoms of diarrhea and pain in the abdomen
FAQ
Q: When is Tofacitinib supposed to act?
A: It could take weeks to indicate clear improvement.
Q: Might this medication contribute to a rise in infection risks?
A: Yes, it could dampen the immune system, thus requiring frequent checks.
Q: Can I stop taking Tofacitinib suddenly?
A: No, discontinuation should be done under medical supervision to prevent flare-ups.
Q: Does this drug have any impact on liver function?
A: Yes, it may affect liver enzymes, so regular monitoring is advised.
FAQ
Apply for PCD Franchise – Not for Job Queries
Apply for PCD Franchise – Not for Job Queries
